Variant report

Variant	nsv1062574
Chromosome Location	chr17:18355380-18530061
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1408)
CpG islands
(count:1529)
Chromatin interactive
region (count:3)
LncRNA
region (count:80)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1408 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:18529043-18529166	K562	blood:	n/a	n/a
2	ARID3A	chr17:18467518-18467720	HepG2	liver:	n/a	n/a
3	ATF1	chr17:18528915-18529148	K562	blood:	n/a	n/a
4	ATF2	chr17:18528880-18529525	GM12878	blood:	n/a	chr17:18528970-18528981
5	ATF3	chr17:18528849-18529308	H1-hESC	embryonic stem cell:	n/a	chr17:18528968-18528981 chr17:18528969-18528980 chr17:18528969-18528982 chr17:18528968-18528983 chr17:18528972-18528982 chr17:18528972-18528980 chr17:18528960-18528980 chr17:18528969-18528979 chr17:18528972-18528982 chr17:18528970-18528981 chr17:18528969-18528979 chr17:18528972-18528979 chr17:18528970-18528981 chr17:18528969-18528982 chr17:18528971-18528979
6	ATF3	chr17:18529033-18529226	GM12878	blood:	n/a	n/a
7	ATF3	chr17:18529020-18529205	K562	blood:	n/a	n/a
8	ATF3	chr17:18528991-18529253	H1-hESC	embryonic stem cell:	n/a	n/a
9	ATF3	chr17:18528866-18529292	GM12878	blood:	n/a	chr17:18528968-18528981 chr17:18528969-18528980 chr17:18528969-18528982 chr17:18528968-18528983 chr17:18528972-18528982 chr17:18528972-18528980 chr17:18528960-18528980 chr17:18528969-18528979 chr17:18528972-18528982 chr17:18528970-18528981 chr17:18528969-18528979 chr17:18528972-18528979 chr17:18528970-18528981 chr17:18528969-18528982 chr17:18528971-18528979
10	BACH1	chr17:18355389-18355575	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr17:18472043-18472169	H1-hESC	embryonic stem cell:	n/a	n/a
12	BACH1	chr17:18362390-18362672	H1-hESC	embryonic stem cell:	n/a	n/a
13	BATF	chr17:18483436-18483734	GM12878	blood:	n/a	n/a
14	BATF	chr17:18410950-18411370	GM12878	blood:	n/a	chr17:18411156-18411166 chr17:18411155-18411166
15	BATF	chr17:18467472-18467685	GM12878	blood:	n/a	n/a
16	BATF	chr17:18509282-18509509	GM12878	blood:	n/a	n/a
17	BATF	chr17:18396335-18396562	GM12878	blood:	n/a	chr17:18396479-18396490
18	BATF	chr17:18379787-18380078	GM12878	blood:	n/a	n/a
19	BATF	chr17:18396259-18396664	GM12878	blood:	n/a	chr17:18396479-18396490
20	BATF	chr17:18528855-18529130	GM12878	blood:	n/a	n/a
21	BATF	chr17:18483425-18483804	GM12878	blood:	n/a	n/a
22	BATF	chr17:18503769-18504272	GM12878	blood:	n/a	n/a
23	BATF	chr17:18528847-18529235	GM12878	blood:	n/a	n/a
24	BATF	chr17:18509195-18509490	GM12878	blood:	n/a	n/a
25	BATF	chr17:18379801-18380128	GM12878	blood:	n/a	n/a
26	BATF	chr17:18496542-18496830	GM12878	blood:	n/a	n/a
27	BATF	chr17:18411051-18411300	GM12878	blood:	n/a	chr17:18411156-18411166 chr17:18411155-18411166
28	BCL11A	chr17:18424410-18424651	GM12878	blood:	n/a	n/a
29	BCL11A	chr17:18503757-18504030	GM12878	blood:	n/a	n/a
30	BCL11A	chr17:18379766-18380162	GM12878	blood:	n/a	n/a
31	BCL11A	chr17:18528910-18529215	GM12878	blood:	n/a	n/a
32	BCL11A	chr17:18379825-18380074	GM12878	blood:	n/a	n/a
33	BCL11A	chr17:18378052-18378384	GM12878	blood:	n/a	n/a
34	BCL11A	chr17:18472981-18473247	H1-hESC	embryonic stem cell:	n/a	n/a
35	BCL11A	chr17:18483453-18483768	GM12878	blood:	n/a	n/a
36	BCL11A	chr17:18509177-18509596	GM12878	blood:	n/a	n/a
37	BCL11A	chr17:18472933-18473174	H1-hESC	embryonic stem cell:	n/a	n/a
38	BCL11A	chr17:18528767-18529227	GM12878	blood:	n/a	n/a
39	BCL11A	chr17:18509267-18509452	GM12878	blood:	n/a	n/a
40	BCLAF1	chr17:18528877-18529395	GM12878	blood:	n/a	n/a
41	BCLAF1	chr17:18528946-18529424	GM12878	blood:	n/a	n/a
42	BHLHE40	chr17:18424672-18424862	GM12878	blood:	n/a	n/a
43	BHLHE40	chr17:18396537-18396565	K562	blood:	n/a	n/a
44	BHLHE40	chr17:18529022-18529213	K562	blood:	n/a	n/a
45	BHLHE40	chr17:18466647-18467016	K562	blood:	n/a	n/a
46	BRCA1	chr17:18528952-18529277	GM12878	blood:	n/a	n/a
47	BRCA1	chr17:18528955-18529155	Hela-S3	cervix:	n/a	n/a
48	CBX3	chr17:18528789-18529275	K562	blood:	n/a	n/a
49	CBX3	chr17:18528996-18529281	K562	blood:	n/a	n/a
50	CEBPB	chr17:18508639-18509020	K562	blood:	n/a	n/a

(count:1529 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:18524503-18524553	HCT-116	colon:	n/a
2	chr17:18380354-18380404	GM12892	blood:	n/a
3	chr17:18529207-18529257	NT2-D1	testis:	n/a
4	chr17:18431043-18431093	HL-60	blood:	n/a
5	chr17:18524503-18524553	HCT-116	colon:	n/a
6	chr17:18380354-18380404	GM12892	blood:	n/a
7	chr17:18529207-18529257	NT2-D1	testis:	n/a
8	chr17:18431043-18431093	HL-60	blood:	n/a
9	chr17:18528589-18528639	HEK293	kidney:	embryo
10	chr17:18528589-18528639	IMR90	lung:	fetal
11	chr17:18431043-18431093	AG04449	skin:	fetal
12	chr17:18431043-18431093	NH-A	brain:	n/a
13	chr17:18475978-18476028	AG04449	skin:	fetal
14	chr17:18430908-18430958	HepG2	liver:	n/a
15	chr17:18380159-18380209	HUVEC	blood vessel:	n/a
16	chr17:18430908-18430958	HRPEpiC	eye:	n/a
17	chr17:18529187-18529237	HepG2	liver:	n/a
18	chr17:18378879-18378929	NHDF-neo	bronchial:	n/a
19	chr17:18397849-18397899	BE2_C	brain:	n/a
20	chr17:18378879-18378929	GM12892	blood:	n/a
21	chr17:18473054-18473104	AG04449	skin:	fetal
22	chr17:18428092-18428142	NHDF-neo	bronchial:	n/a
23	chr17:18380159-18380209	SK-N-SH	brain:	n/a
24	chr17:18429951-18430001	NHBE	bronchial:	n/a
25	chr17:18421335-18421385	U87	brain:	n/a
26	chr17:18524503-18524553	A549	lung:	n/a
27	chr17:18529207-18529257	HL-60	blood:	n/a
28	chr17:18476399-18476449	PANC-1	pancreas:	n/a
29	chr17:18380159-18380209	AG09309	skin:	n/a
30	chr17:18379129-18379179	Jurkat	blood:	n/a
31	chr17:18476310-18476360	GM12892	blood:	n/a
32	chr17:18524503-18524553	HEEpiC	esophagus:	n/a
33	chr17:18527483-18527533	Caco-2	colon:	n/a
34	chr17:18529207-18529257	AoSMC	blood vessel:	n/a
35	chr17:18429951-18430001	HL-60	blood:	n/a
36	chr17:18476059-18476109	AG04449	skin:	fetal
37	chr17:18476059-18476109	HMEC	breast:	n/a
38	chr17:18476399-18476449	HUVEC	blood vessel:	n/a
39	chr17:18380354-18380404	HCPEpiC	choroid plexus:	n/a
40	chr17:18378879-18378929	AG09319	gingival:	n/a
41	chr17:18529285-18529335	PANC-1	pancreas:	n/a
42	chr17:18476310-18476360	ovcar-3	ovarian:	n/a
43	chr17:18419896-18419946	HL-60	blood:	n/a
44	chr17:18380354-18380404	ovcar-3	ovarian:	n/a
45	chr17:18430908-18430958	AG10803	skin:	n/a
46	chr17:18429951-18430001	HepG2	liver:	n/a
47	chr17:18380159-18380209	PFSK-1	brain:	n/a
48	chr17:18529207-18529257	MCF10A-Er-Src	breast:	n/a
49	chr17:18527483-18527533	T-47D	breast:	n/a
50	chr17:18528568-18528618	AG04449	skin:	fetal

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:18528651..18529582-chr17:18854802..18855667,3	MCF-7	breast:
2	chr17:18222850..18223360-chr17:18466465..18467335,2	MCF-7	breast:
3	chr17:18528592..18529197-chr17:18854872..18855642,2	MCF-7	breast:

(count:80 , 50 per page) page: 1 2

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM106A-2	chr17:18436661-18436946	ENSG00000273018.1
2	lnc-FAM106A-2	chr17:18431887-18432061	ENSG00000273018.1
3	lnc-FAM106A-2	chr17:18446987-18447029	ENSG00000273018.1
4	lnc-FAM106A-2	chr17:18435820-18435911	ENSG00000273018.1
5	lnc-FAM106A-2	chr17:18422796-18422988	NONHSAT146382
6	lnc-FAM106A-2	chr17:18525812-18525882	NONHSAT146390
7	lnc-FAM106A-1	chr17:18427880-18430160	NR_026809
8	lnc-FAM106A-2	chr17:18523399-18523578	NONHSAT146390
9	lnc-FAM106A-2	chr17:18528417-18528854	NONHSAT146390
10	lnc-FAM106A-2	chr17:18420696-18420787	ENSG00000273018.1
11	lnc-FAM106A-2	chr17:18422796-18422988	NONHSAT146381
12	lnc-AL353997.5.1-6	chr17:18395483-18395859	NONHSAT146378
13	lnc-FAM106A-2	chr17:18444241-18444277	NONHSAT146384
14	lnc-FAM106A-2	chr17:18446987-18447029	ENSG00000273018.1
15	lnc-FAM106A-2	chr17:18435820-18436192	ENSG00000273018.1
16	lnc-AL353997.5.1-5	chr17:18387189-18387649	NONHSAT146376
17	lnc-FAM106A-2	chr17:18420696-18420787	ENSG00000273018.1
18	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
19	lnc-FAM106A-2	chr17:18431887-18432061	ENSG00000273018.1
20	lnc-FAM106A-2	chr17:18431887-18432061	ENSG00000273018.1
21	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
22	lnc-TBC1D28-3	chr17:18508369-18508669	NONHSAT146389
23	lnc-FAM106A-2	chr17:18420633-18420787	NONHSAT146382
24	lnc-FAM106A-2	chr17:18445402-18445501	ENSG00000273018.1
25	lnc-FAM106A-2	chr17:18426965-18427191	ENSG00000273018.1
26	lnc-FAM106A-2	chr17:18422958-18422988	ENSG00000273018.1
27	lnc-FAM106A-2	chr17:18420604-18420787	ENSG00000273018.1
28	lnc-FAM106A-2	chr17:18427091-18427191	ENSG00000273018.1
29	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
30	lnc-FAM106A-2	chr17:18430884-18431074	ENSG00000273018.1
31	lnc-FAM106A-2	chr17:18427457-18427714	ENSG00000273018.1
32	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
33	lnc-AL353997.5.1-5	chr17:18380114-18380207	NONHSAT146376
34	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
35	lnc-FAM106A-2	chr17:18420696-18420787	ENSG00000273018.1
36	lnc-FAM106A-2	chr17:18427120-18427191	ENSG00000273018.1
37	lnc-FAM106A-2	chr17:18435820-18436348	ENSG00000273018.1
38	lnc-FAM106A-2	chr17:18431887-18432061	ENSG00000273018.1
39	lnc-FAM106A-2	chr17:18420696-18420787	ENSG00000273018.1
40	lnc-FAM106A-2	chr17:18435820-18435911	ENSG00000273018.1
41	lnc-FAM106A-2	chr17:18454820-18454999	ENSG00000273018.1
42	lnc-FAM106A-2	chr17:18436395-18436705	NONHSAT146384
43	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
44	lnc-FAM106A-2	chr17:18427091-18427711	ENSG00000273018.1
45	lnc-FAM106A-2	chr17:18454820-18455019	ENSG00000273018.1
46	lnc-FAM106A-2	chr17:18420725-18420787	ENSG00000273018.1
47	lnc-FAM106A-2	chr17:18420696-18420787	ENSG00000273018.1
48	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
49	lnc-FAM106A-2	chr17:18431900-18432061	ENSG00000273018.1
50	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1

No data

Variant related genes	Relation type
USP32P2	TF binding region
ENSG00000267492	TF binding region
SRP68P2	TF binding region
NOS2P2	TF binding region
LGALS9C	TF binding region
ENSG00000227919	TF binding region
RN7SL639P	TF binding region
TNPO1P2	TF binding region
ENSG00000227077	TF binding region
FAM106A	TF binding region
CCDC144B	TF binding region
ENSG00000273018	TF binding region
USP32P2	CpG island
ENSG00000267492	CpG island
SRP68P2	CpG island
NOS2P2	CpG island
LGALS9C	CpG island
ENSG00000227919	CpG island
RN7SL639P	CpG island
TNPO1P2	CpG island
ENSG00000227077	CpG island
FAM106A	CpG island
CCDC144B	CpG island
ENSG00000273018	CpG island
ENSG00000154025	chromatin interactions

Extended variants
information (count: 4019 )
Associated
traits (count: 168 )

Variant overlapped rSNPs/rCNVs (count:4019 , 50 per page) page: 1 2 3 4 5 6 7 ... 81

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs140274939	chr17:18355400-18355401	Weak transcription Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
2	rs577993901	chr17:18355404-18355405	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs534034209	chr17:18355407-18355408	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs554284833	chr17:18355424-18355425	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs62076318	chr17:18355428-18355429	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs375677960	chr17:18355434-18355435	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs496440	chr17:18355439-18355440	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs367770134	chr17:18355478-18355479	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs542432685	chr17:18355479-18355480	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs562406894	chr17:18355489-18355490	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs184220188	chr17:18355520-18355521	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs148418132	chr17:18355521-18355522	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs201361562	chr17:18355559-18355560	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs189614147	chr17:18355566-18355567	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs181104895	chr17:18355609-18355610	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs527328867	chr17:18355614-18355615	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs540723117	chr17:18355631-18355632	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs561047822	chr17:18355660-18355661	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs6502655	chr17:18355670-18355671	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs549619360	chr17:18355740-18355741	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs569499636	chr17:18355845-18355846	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs532025622	chr17:18355861-18355862	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs201801241	chr17:18355886-18355887	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs552141894	chr17:18355957-18355958	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs571546082	chr17:18356013-18356014	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs374418416	chr17:18356027-18356028	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs534198360	chr17:18356040-18356041	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs202020403	chr17:18356054-18356055	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs79203021	chr17:18356059-18356060	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs541037345	chr17:18357177-18357178	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs531995968	chr17:18357195-18357196	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs560792466	chr17:18357202-18357203	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs191183437	chr17:18357203-18357204	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs77085790	chr17:18357218-18357219	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs79787939	chr17:18357240-18357241	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs563061679	chr17:18357245-18357246	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs531987104	chr17:18357255-18357256	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs150392707	chr17:18357270-18357271	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs552054134	chr17:18357280-18357281	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs60950878	chr17:18357296-18357297	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs7405892	chr17:18357302-18357303	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs371712635	chr17:18357306-18357307	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs2608270	chr17:18357315-18357316	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs7405911	chr17:18357413-18357414	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs7405875	chr17:18357422-18357423	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs7405888	chr17:18357434-18357435	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
47	rs7405975	chr17:18357449-18357450	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs75011745	chr17:18357609-18357610	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs186524586	chr17:18357646-18357647	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs7405904	chr17:18357651-18357652	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:168)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Autism	22543975	CNVD
Ovarian cancer	22355333	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Sezary syndrome	18413736	CNVD
Medulloblastoma	16783165	CNVD
Recurrent pregnancy loss	19789632	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Tetralogy of Fallot	22912587	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Autism	21865298	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	19212409	CNVD

Chromatin state (count:641 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:18351400-18355400	Weak transcription	NHEK	skin
2	chr17:18354600-18355400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
3	chr17:18354600-18355400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
4	chr17:18355400-18355600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr17:18355400-18355600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr17:18355400-18355800	Enhancers	NHEK	skin
7	chr17:18355600-18355800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr17:18355600-18355800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr17:18361000-18362400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr17:18361600-18361800	Enhancers	Hela-S3	cervix
11	chr17:18361600-18362000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr17:18362000-18362400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
13	chr17:18362200-18362600	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
14	chr17:18362200-18362600	Active TSS	A549	lung
15	chr17:18362200-18362800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr17:18362400-18362600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr17:18362400-18362600	Bivalent Enhancer	Fetal Lung	lung
18	chr17:18362400-18362600	Active TSS	Hela-S3	cervix
19	chr17:18362400-18362800	Enhancers	H1 Cell Line	embryonic stem cell
20	chr17:18362400-18362800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr17:18362400-18362800	Enhancers	HUES64 Cell Line	embryonic stem cell
22	chr17:18362400-18362800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr17:18362400-18362800	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr17:18362400-18363400	Enhancers	HUES48 Cell Line	embryonic stem cell
25	chr17:18362600-18362800	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
26	chr17:18362600-18362800	Enhancers	Muscle Satellite Cultured Cells	--
27	chr17:18362600-18362800	Flanking Active TSS	Hela-S3	cervix
28	chr17:18362600-18362800	Enhancers	Osteobl	bone
29	chr17:18362600-18372000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr17:18367200-18367400	Enhancers	Fetal Intestine Large	intestine
31	chr17:18370000-18380000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr17:18370400-18370600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr17:18370600-18371000	Enhancers	Esophagus	oesophagus
34	chr17:18371000-18372000	Weak transcription	Esophagus	oesophagus
35	chr17:18372000-18372200	Enhancers	Esophagus	oesophagus
36	chr17:18372000-18372200	Enhancers	NHEK	skin
37	chr17:18372000-18372400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr17:18372200-18375200	Weak transcription	Esophagus	oesophagus
39	chr17:18372200-18379800	Weak transcription	NHEK	skin
40	chr17:18377800-18378000	Enhancers	Primary hematopoietic stem cells short term culture	blood
41	chr17:18377800-18382600	Weak transcription	Esophagus	oesophagus
42	chr17:18378000-18378800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
43	chr17:18378200-18378400	Enhancers	Monocytes-CD14+_RO01746	blood
44	chr17:18378200-18381400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr17:18378600-18379600	Weak transcription	Monocytes-CD14+_RO01746	blood
46	chr17:18378800-18379000	Enhancers	Primary hematopoietic stem cells short term culture	blood
47	chr17:18379000-18379800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
48	chr17:18379200-18380400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
49	chr17:18379200-18380600	Enhancers	Primary T helper naive cells from peripheral blood	blood
50	chr17:18379600-18380000	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links